LANSDOWNE PARTNERS (UK) LLP - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 14 filers reported holding SUMMIT THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LANSDOWNE PARTNERS (UK) LLP ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q2 2020$7,922,000
-21.0%
2,667,350
-36.9%
0.33%
-40.4%
Q1 2020$10,022,000
+292.3%
4,228,700
+164.8%
0.56%
+704.3%
Q4 2019$2,555,000
-10.6%
1,596,6660.0%0.07%
-9.2%
Q3 2019$2,858,000
+41.5%
1,596,6660.0%0.08%
+52.0%
Q2 2019$2,020,000
-30.9%
1,596,6660.0%0.05%
-23.1%
Q1 2019$2,922,000
+59.2%
1,596,6660.0%0.06%
+140.7%
Q4 2018$1,836,000
-48.2%
1,596,6660.0%0.03%
-27.0%
Q3 2018$3,545,000
-9.4%
1,596,6660.0%0.04%0.0%
Q2 2018$3,912,000
-81.0%
1,596,6660.0%0.04%
-82.7%
Q1 2018$20,597,000
+16.4%
1,596,6660.0%0.21%
+31.3%
Q4 2017$17,691,000
-11.7%
1,596,6660.0%0.16%
-22.0%
Q3 2017$20,038,000
+89.2%
1,596,666
+71.7%
0.21%
+127.2%
Q2 2017$10,593,000
-14.2%
930,0000.0%0.09%
-14.0%
Q1 2017$12,346,000
+55.1%
930,0000.0%0.11%
+50.7%
Q4 2016$7,961,000
-5.6%
930,0000.0%0.07%
-2.7%
Q3 2016$8,430,000
+12.0%
930,0000.0%0.07%
+4.3%
Q2 2016$7,524,000
+18.6%
930,0000.0%0.07%
+40.0%
Q1 2016$6,343,000
-40.7%
930,0000.0%0.05%
-31.5%
Q4 2015$10,695,000
+10.5%
930,0000.0%0.07%
-11.0%
Q3 2015$9,681,000
-1.4%
930,0000.0%0.08%
-2.4%
Q2 2015$9,823,000
-14.8%
930,0000.0%0.08%
-19.2%
Q1 2015$11,523,000930,0000.10%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 212,018$2,349,0000.28%
Granite Point Capital Management, L.P. 242,113$2,683,0000.26%
LANSDOWNE PARTNERS (UK) LLP 1,596,666$17,691,0000.16%
Point72 Asset Management, L.P. 785,600$8,704,0000.04%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 80,000$886,0000.02%
AXA S.A. 282,760$3,133,0000.01%
Polar Capital LLP 100,000$1,108,0000.01%
ACADIAN ASSET MANAGEMENT LLC 144,083$1,595,0000.01%
First Eagle Investment Management, LLC 194,900$2,159,0000.01%
Alyeska Investment Group, L.P. 50,000$554,0000.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders